Skip to main content
Fig. 1 | Cost Effectiveness and Resource Allocation

Fig. 1

From: Healthcare costs of congenital cytomegalovirus (cCMV) disease in infants during the first two years of life: a retrospective German claims database analysis

Fig. 1

Patient selection process. InGef Institute for Applied Health Research Berlin, cCMV congenital cytomegalovirus, CMV cytomegalovirus, cCMV90 infants with cCMV diagnosis during the first 90 days of life, “Representative” infants with no cCMV or CMV diagnosis in the observation period; cCMV21-S, infants with cCMV diagnosis and symptoms during the first 21 days of life, “Healthy” infants with no ICD-10-GM diagnosis (except Z-diagnoses) until 4th preventive health checkup and no cCMV or CMV diagnosis in the observation period, DoL days of life, ICD-10-GM International Statistical Classification of Diseases and Related Health Problems, 10th Revision, German Modification, U4 fourth preventive checkup examination

Back to article page